Announced
Financials
Tags
Private
digital surgery platform
Minority
Completed
Digital Services
Single Bidder
Venture Capital
United States
Acquisition
Friendly
Private Equity
Cross Border
Synopsis
PFM Health Sciences led a $100m Series C round in Caresyntax, with participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital, Arno Capital, Rezayat Investments, IPF Partners, the Relyens Group, and Surgical.AI. "Operating rooms need to perform as effectively and efficiently as possible, and this is especially true now to make up for the surgical backlog driven by the pandemic. With better technology to safely automate surgical pathways while generating decision-grade real-world evidence, we will improve health care decision-making, mitigate surgical risks, and advance high-value medical technology," Dennis Kogan, Caresyntax Founder and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.